Beyond Type 1 and JDRF Come Together to Drive Greater Patient Trust, Engagement & Research Participation
Beyond Type 1 has partnered with JDRF—the world’s leading nonprofit funder of Type 1 diabetes (T1D) research—to educate the T1D […]
Beyond Type 1 has partnered with JDRF—the world’s leading nonprofit funder of Type 1 diabetes (T1D) research—to educate the T1D […]
Researchers from Johns Hopkins University and other prominent institutions conclude that chloroquine and hydroxychloroquine could be dangerous when combined with […]
Two clinical investigators from the Jacobs School of Medicine and Biomedical Sciences at the University of Buffalo (UB) participated in […]
New Zealand’s University of Otago researchers are participating in a larger clinical investigation—a €4.8 million international study in how to prevent tuberculosis […]
University of Tennessee (UT) Health Science Center Memphis investigators secured $2 million to pursue their potentially breakthrough diabetes research. The […]
The American Diabetes Association (ADA) has awarded the Pathway to Stop Diabetes grants, totaling $3.25 million, to two promising investigators. […]
Insulin resistance, the leading cause of Type 2 diabetes, is the target of a new drug under development in Israel. […]
Diabetes management app, Quin, powered by algorithmic insights and machine learning, helps users decide when and how much insulin they should […]
The U.S. Food and Drug Administration (FDA) has approved an artificial pancreas system that is based on the technology from […]
The University of Notre Dame have received a $4.6 million from the Department of Defense as a team of “Fighting […]